|
Cemiplimab Plus Gemcitabine Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Cemiplimab, Gemzar, Libtayo, REGN2810
La Jolla, California1 trial
Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
University of California, San Diego
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.